A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple disease targets.

In the historic period, the growth can be attributed to the increasing prevalence of chronic diseases, heightening demand for targeted therapies, advancements in drug delivery systems and enhanced ...

Argenx wants to get in on the macrocyclic peptide action, penning a deal worth $1.5 billion in biobucks with Californian ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

Researchers reveal how hydration shapes peptide assembly on 2D materials, offering new insights for bioelectronics and ...

Kanazawa University, report in Small, on how short peptides self-assemble linearly on atomically-thick solid surfaces, such ...

Breakthrough in AI-powered drug discovery validates HYFT™-driven peptide design, with broad potential across multiple therapeutic areas The results validate the power of IPA’s LENSai ...

ProteinQure’s lead candidate, PQ203, is a first-in-class peptide-drug conjugate designed to target the sortilin receptor, which is overexpressed in many solid tumors, including TNBC.

Conclusion: dsRNA-selective peptides with high affinity and selectivity were successfully identified using two distinct strategies involving rational design and combinatorial library screening. These ...

Scientists design peptides to enhance drug efficacy New York Monday, January 27, 2025, 17:00 Hrs [IST] A team of scientists has developed a groundbreaking approach using specially designed peptides to ...

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumour efficacy, as ...